These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3199607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Copper-induced alteration of muscarinic binding in bovine adrenal medulla.
    Yamanaka K, Kigoshi S, Muramatsu I.
    Jpn J Pharmacol; 1986 Jul; 41(3):415-8. PubMed ID: 3761756
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4119-24. PubMed ID: 3689439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased agonist affinity is induced in tetranitromethane-modified muscarinic receptors.
    Gurwitz D, Sokolovsky M.
    Biochemistry; 1985 Dec 31; 24(27):8086-93. PubMed ID: 4092058
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI.
    J Pharmacol Exp Ther; 1987 Jan 31; 240(1):51-8. PubMed ID: 3806397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB, Creese I.
    Mol Pharmacol; 1986 Aug 31; 30(2):96-103. PubMed ID: 3755499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. M2 muscarinoceptor-associated ionophore at the cat adrenal medulla.
    Borges R, Ballesta JJ, García AG.
    Biochem Biophys Res Commun; 1987 Apr 29; 144(2):965-72. PubMed ID: 3555498
    [Abstract] [Full Text] [Related]

  • 16. Rat brain and heart muscarinic receptors: modification with tetranitromethane.
    Gurwitz D, Sokolovsky M.
    Biochem Biophys Res Commun; 1985 Sep 30; 131(3):1124-31. PubMed ID: 4052081
    [Abstract] [Full Text] [Related]

  • 17. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR, Wolfe BB.
    J Pharmacol Exp Ther; 1985 Jul 30; 234(1):37-44. PubMed ID: 3839265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK, Cubeddu LX.
    J Pharmacol Exp Ther; 1987 Jan 30; 240(1):203-15. PubMed ID: 3806384
    [Abstract] [Full Text] [Related]

  • 20. Agonist and antagonist binding of muscarinic acetylcholine receptors purified from porcine brain: interconversion of high- and low-affinity sites by sulfhydryl reagents.
    Berstein G, Haga K, Haga T, Ichiyama A.
    J Neurochem; 1988 Jun 30; 50(6):1687-94. PubMed ID: 3373209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.